491 related articles for article (PubMed ID: 25410893)
1. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
[TBL] [Abstract][Full Text] [Related]
2. Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.
Haga SB; Allen LaPointe NM; Moaddeb J; Mills R; Patel M; Kraus WE
Pharmacogenomics; 2014 Nov; 15(14):1729-1737. PubMed ID: 25493566
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
[No Abstract] [Full Text] [Related]
5. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of pharmacogenetic testing into medication therapy management.
Haga SB; Moaddeb J; Mills R; Patel M; Kraus W; Allen LaPointe NM
Pharmacogenomics; 2015 Nov; 16(17):1931-41. PubMed ID: 26555559
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
[TBL] [Abstract][Full Text] [Related]
8. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
Haga SB; Moaddeb J; Mills R; Voora D
Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
[TBL] [Abstract][Full Text] [Related]
9. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacists' experience with pharmacogenetic testing.
Moaddeb J; Mills R; Haga SB
J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
[TBL] [Abstract][Full Text] [Related]
11. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
[TBL] [Abstract][Full Text] [Related]
12. Patient experiences with pharmacogenetic testing in a primary care setting.
Haga SB; Mills R; Moaddeb J; Allen Lapointe N; Cho A; Ginsburg GS
Pharmacogenomics; 2016 Oct; 17(15):1629-1636. PubMed ID: 27648637
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
[TBL] [Abstract][Full Text] [Related]
14. Description of an Established, Fee-for-Service, Office-Based, Pharmacist-Managed Pharmacogenomics Practice.
Schuh MJ; Crosby S
Sr Care Pharm; 2019 Dec; 34(10):660-668. PubMed ID: 31818351
[No Abstract] [Full Text] [Related]
15. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
[No Abstract] [Full Text] [Related]
16. Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
Haga SB; Mills R; Moaddeb J; Allen LaPointe N; Cho A; Ginsburg GS
Pharmacogenomics; 2017 Mar; 18(4):359-367. PubMed ID: 28244812
[TBL] [Abstract][Full Text] [Related]
17. Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.
Haga SB; Mills R; Moaddeb J; Liu Y; Voora D
Pharmgenomics Pers Med; 2021; 14():877-886. PubMed ID: 34290521
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
Haga SB; Mills R; Moaddeb J
Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
[TBL] [Abstract][Full Text] [Related]
19. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
[TBL] [Abstract][Full Text] [Related]
20. Integrating pharmacogenetic testing into primary care.
Haga SB
Expert Rev Precis Med Drug Dev; 2017; 2(6):327-336. PubMed ID: 31853504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
